Hypocaloric diet is a key component of the weight-reducing treatment of obesity and obesity-related disorders. Hypocaloric diets and the associated weight reduction promote improvement of metabolic profile of obese individuals. Among the mechanisms that underlie this beneficial metabolic outcome, the diet-induced modifications of morphological and functional characteristics of human adipose tissue (AT) are believed to have an important role. Prospective studies of hypocaloric weight-reducing dietary intervention demonstrate effects on adipocyte metabolism, namely lipolysis and lipogenesis, and associated changes of the adipocyte size. The endocrine function of AT, which involves cytokine and adipokine production by adipocytes, as well as by cells of stromavascular fraction, is also regulated by dietary intervention. Related inflammatory status of AT is modulated also as a consequence of the changes in recruitment of immune cells, mainly macrophages, in AT. Here, we give an overview of metabolic and endocrine modifications in human AT induced by a variety of hypocaloric diets.
INTRODUCTION

Dietary intervention is a key component of obesity treatment.
Hypocaloric diets induce a fat mass reduction as well as an improvement of metabolic profile of the obese individual. [1] [2] [3] As obesity is associated with a number of disturbances of morphological and functional characteristics of adipose tissue (AT), 4 it may be hypothesized that the beneficial effects of hypocaloric diets are associated with, or even mediated by, a reestablishment of AT characteristics and functions seen in lean subjects. AT consists of a number of different cellular populations (adipocytes, preadipocytes, macrophages, other immune cells, and endothelial cells) and the diet-induced modifications may occur in each of these cellular populations. Accordingly, in the first part of this review, the attention is paid to the morphological and functional changes of adipocytes, namely those of adipocyte size, lipolysis and lipogenesis occurring, during prospective studies using hypocaloric weight-reducing dietary intervention. Subsequent parts deal with the diet-induced changes of characteristics related to adipocytes as well as to other cellular populations, such as production of cytokines and adipokines, expression of immunityrelated genes and recruitment of macrophages in the AT. In all the studies (except for a few studies of whole-body lipolysis), the above-mentioned characteristics have been investigated in subcutaneous AT (SCAT) mostly derived from abdominal area.
The goal of this review is to provide a general idea of the type of changes occurring in AT during the dietary intervention and not to give a complete list of randomized studies on this topic. Even though the results obtained in the studies of weight loss induced by bariatric surgery are occasionally cited, mostly in order to demonstrate long-term effects of hypocaloric intake, the attention is paid mainly to the effects of weight loss induced by hypocaloric diets, that is, very-low-calorie diets (VLCD) and low-calorie diets (LCD). Both diets are designed to be nutritionally balanced and differ in the severity of caloric restriction. Daily calorie intake during LCD is usually 2100-2500 kJ per day lower than the estimated daily energy expenditure and is 43400 kJ per day, VLCD comprises the daily energy intake of o3400 kJ per day and is frequently administered as a liquid diet. 5 VLCD is usually administered 4-8 weeks, whereas LCD is used for longer periods of time, commonly for 2-3 months.
ADIPOCYTE SIZE
Among the morphological adaptations to hypocaloric diet, the change in adipocyte size was historically the first point of attention. The key result of hypocaloric diets, reduction in fat mass, is believed to be caused primarily by reduction of the size of the hypertrophic adipocytes, whereas increased adipocyte death has not been proved to contribute substantially to the weight loss. 6 The diminishment of adipocyte size may be also an important trigger of the diet-induced modifications of metabolic and endocrine function of the adipocyte. In fact, the adipocyte size was shown to be associated with basal and stimulated lipolysis rate and insulin-stimulated lipogenesis 7 and, also, with secretion and expression of several adipokines. 8 Since 70s, the average adipocyte size was measured using microscopy in a number of studies, primarily targeted to investigation of lipolysis regulation in vitro, and a decrease of average adipocyte size was systematically reported. At the end of 4 weeks' VLCD, the average adipocyte size was found to be reduced by 11-12% in abdominal SCAT. [9] [10] [11] After 12 weeks' LCD, the adipocyte size was reduced by 15-20% in both abdominal and gluteal SCAT. 12 The reduction of the adipocyte size found after longer follow-up, at the weight maintenance phase, was of the order of 40% 13 or 26% in abdominal SCAT and 22% in gluteal SCAT.
14 Surprisingly, no reduction of adipocyte size in abdominal (but not in gluteal) SCAT was found after 20 weeks' LCD in one study.
Few studies paid attention also to the diet-induced changes of the adipocyte size distribution and not only to the average adipocyte size. In a study on type 2 diabetes patients submitted to 1-year dietary intervention combined with exercise, the authors stratified the adipocytes into four subfractions in respect to the cell size. 16 At the end of intervention, the adipocyte size was reduced just in subfraction of 'large' adipocytes, while the other three remained unchanged. In another study, using electron microscopy, the response was variable in a group of six patients submitted to 6 weeks' LCD: in subjects with higher proportion of large adipocytes (hypertrophic obesity), the authors observed a shift from the fraction of large adipocytes towards the small ones, whereas in subjects with higher proportion of small adipocytes (hyperplasic obesity) no shift between the fractions occurred. 17 Identical result was observed in our own study (not published) after 6 months' dietary intervention. These investigations suggest that individuals with hypertrophic obesity-who are at higher metabolic risk 6, [18] [19] [20] -are more responsive to the adipocyte sizereducing effect of hypocaloric diets in comparison with those with small adipocytes, that is, with hyperplasic obesity.
HYPOCALORIC DIET AND LIPOLYSIS
Calorie restriction promotes a reduction of the adipocyte size that is a consequence of the decreased triacylglycerol (TAG) content in the adipose cells. TAGs are mobilized from adipocytes in the process of lipolysis. The products of TAG breakdown, nonesterified fatty acids (NEFA) and glycerol, are released from adipocyte into the interstitial space of AT and, subsequently, into the circulation. 21, 22 In the condition of restricted calorie intake, the AT-derived NEFA provide energy substrate for the skeletal muscle, liver and myocardium. TAGs are hydrolyzed by three major AT lipases: adipose triglyceride lipase (ATGL), hormone-sensitive lipase (HSL) and monoacylglycerol lipase. Activity of HSL and, indirectly through cofactors, also of ATGL, is dependent on a cascade of intracellular signals initiated by a number of circulating hormones. The hormones currently being considered as the most relevant ones in the regulation of lipolysis are catecholamines (stimulating lipolysis through b1-, b2-and inhibiting through a2-adrenoreceptors), insulin (inhibiting lipolysis), atrial natriuretic peptide and the growth hormone (both stimulating lipolysis). However, a number of other endogenous signals that exert lipolysisregulating action have been reported, including cytokines TNFa and IL-6, lactate, adenosin and others (reviewed in Lafontan M et al.
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). Obesity is associated with dysregulation of lipolysis. An increase in the overall 'basal' lipolysis and resistance to 'stimulated', catecholamine-induced lipolysis has been demonstrated in obese individuals. 23 The dietary intervention studies investigated both features of lipolysis: responsiveness of lipolysis to several regulatory signals as well as modifications of the basal lipolytic rate. Various methods of investigation of AT lipolysis and its regulation have been used in dietary studies, being based mostly on measurements of glycerol kinetics or release: (1) whole-body AT lipolysis in vivo using stable tracer methodology (for example, Horowitz et al. 24 ), (2) regional lipolysis of SCAT in vivo using measurement of arterio-venous differences and simultaneous measurement of AT blood flow (ATBF), 25, 26 (3) microdialysis as an alternative method for estimation of regional lipolysis in SCAT in situ, [27] [28] [29] [30] (4) lipolysis assessed in vitro in isolated adipocytes 9, 12, 27, [31] [32] [33] and finally (5) gene expression of key substances of lipolytic cascade in samples of whole AT. 9, 30, 34 Short-term fasting A short physiological calorie restriction is represented by overnight fast. Prolongation of fasting to 22 h in obese 24, 35 or 72 h in lean subjects 26 induced an increase of the whole-body basal, that is, non-stimulated, lipolysis measured by stable isotope methodology. In agreement, 22 h fasting increased in situ lipolysis in SCAT in abdominal (but not in femoral) depot. 24 In this study, plasma insulin levels (decreasing during the fasting) appeared as a determinant of the whole-body lipolysis. 24 VLCD Short-term (up to 4 weeks) VLCD was associated with no change of basal lipolysis when measured by microdialysis in situ, [27] [28] [29] 33 whereas an increase was found in most of the studies using isolated adipocytes in vitro. 9, 10, 36 In a study, when VLCD was applied for a longer period (8-12 weeks) and the investigation was made after subsequent weight-maintenance period, the basal lipolysis was reduced 32 and, thus, the response approached that after long-term dietary interventions (see below-weightmaintenance phase).
Insulin antilipolytic action remained unchanged after short VLCD when evaluated in situ by microdialysis during hyperinsulinemic euglycemic clamp. 29 In vitro, however, VLCD reduced significantly the maximal antilipolytic effect of insulin. 10 Large part of the studies investigating the effects of diet on AT lipolysis paid attention to the catecholamine regulatory pathway in abdominal SCAT. After 4 weeks of VLCD, responsiveness of AT lipolysis to stimulation by a nonselective b-adrenergic (isoprenaline) and selective b1-adrenergic stimulation was found to be enhanced when measured by microdialysis. 27, 28, 33 Similarly, in situ responsiveness of SCAT to atrial natriuretic peptide, a powerful lipolysis-stimulating hormone, increased during VLCD. 27 These in situ findings were paralleled by several studies that investigated catecholamine regulation of lipolysis in isolated adipocytes in vitro. After VLCD, an increase in isoprenaline-, noradrenalin-, b2-adrenoceptor or epinephrinestimulated lipolysis was found. 9, 27, 33 This was associated with an increase of the responsiveness to post-receptor signals of the lipolytic cascade (isobutylmethylxantine and dibutyryl cyclic adenosine monophosphate) 9 and an increase in the density of b-adrenoreceptors. 32 However, the VLCD-induced increase in b-adrenergic-stimulated lipolysis in vitro was not found in number of older studies 10, 11, [36] [37] [38] and the reason of the discrepancy is not clear. One of the relevant factors could be the mode of standardization of lipolytic rate (to number of cells versus gram of tissue). Regarding the antilipolytic action of epinephrine mediated by a2-adrenoreceptors, it was found to be enhanced after VLCD when measured in vitro. 11, 36, 37 Enzymatic activity, protein levels or mRNA-expression of lipases, the key effectors of lipolysis, in SCAT were analyzed in several studies. ATGL and HSL mRNA and protein levels seem to be highly correlated, indicating a tight coregulation and transcriptional control of the two lipases. 34 However, it appears that HSL is associated with regulation of hormone-stimulated lipolysis more than ATGL, while both lipases are important for their role in the control of basal lipolysis in human fat cells. 39 Indeed, there was a parallel between the evolution of the diet-induced changes of catecholamine-stimulated lipolysis and that of indices of HSL expression or activity, namely an increase after short-term VLCD in the study of Stich et al. 9 or absence of change in the study of Hellstrom et al. 10 Notably, the diet-induced changes in lipolysis regulation might be genotype-dependent: when eight pairs of monozygotic twins were followed during VLCD, the diet-induced elevation of both, stimulated and basal, lipolysis showed a significant intrapair resemblance. 9 LCD LCD represents mild calorie restriction that has to be maintained for longer period of time in order to induce the relevant weight loss. Thus, presumably, adaptation of AT to this type of negative energy balance may be regulated differently.
Adaptation to hypocaloric diet L Rossmeislová et al After 12-15 weeks period of LCD, no change 12, 40 in basal lipolysis measured in vitro was observed. In microdialysis studies, the baseline glycerol levels did not change during 12 week' LCD, 30 similarly to VLCD. The increased sensitivity of isolated adipocytes of SCAT to nonselective and b2-adrenergic stimulation in vitro found in VLCD studies were present after 8-15 weeks of LCD as well. 12 At the same time, a reduction of sensitivity to a2-mediated inhibition of lipolysis in vitro was observed, while the density of a2-adrenoreceptors was not changed. 12 The in situ study using microdialysis confirmed this finding, that is, decrease in a2-adrenoceptor-mediated inhibition of lipolysis, after 12 weeks' LCD. 30 Moreover, mRNA expression of a2-receptors was found to be decreased in the same study, 30 even though the change in mRNA levels of a2-receptors was not detected elsewhere. 12 LCD induced a decrease of mRNA expression and protein levels of both lipases, HSL and ATGL, 34 or no change of mRNA HSL in another study, 30 while HSL activity was found even increased. 12 Weight-maintenance phase The weight-maintenance phase represents the stabilization of adaptation of the body to a new energy balance state. Weightmaintenance state may be reached and evaluated at several months or longer periods of time after initiation of the dietary intervention.
In a study where lipolysis was assessed 3 years after initiation of the weight-reducing program, basal lipolysis in vitro was lower when compared with the pre-diet condition. 31 At the same time, the maximum ability of insulin to inhibit lipolysis in isolated adipocytes was improved. 31 Furthermore, the in vitro responsiveness of isolated adipocytes of SCAT to all b-adrenergic stimuli was actually lower when compared with the pre-diet condition 31 and the same was true for signaling at the post-receptor level of the lipolytic pathway. In situ, in contrast to the effect of acute calorie restriction, Kolehmainen et al. 41 found unchanged isoprenalinestimulated lipolysis measured by microdialysis in patients examined 1 year after bariatric surgery. Finally, weight-maintenance phase after bariatric surgery was also connected with the decrease of mRNA HSL expression in women but not men. 41 Details of the studies dealing with the effects of hypocaloric diets on lipolysis are presented in Table 1 . The extensive overview of these studies provides a quite variable picture and the factors that may be determinants of the variability of the results are not straightforward. It must be taken into account that the results obtained by in vivo/in situ techniques cannot be simply compared with those obtained in vitro, using biopsy-derived AT samples. 42 Nevertheless, it might be suggested that the observed variability of the effects of hypocaloric diet on lipolysis regulation may be ascribed partly to the degree of calorie restriction and duration of the dietary intervention. In general, it seems that a severe shortterm calorie restriction, such as fasting and VLCD, promotes an increase of the basal lipolysis and an increase of responsiveness of AT to the lipolysis stimulators (the latter being valid at least for more recent studies). The increased responsiveness persists throughout the dynamic phase of the diet, that is, during 2-3 months of LCD, and then decreases bellow the pre-diet conditions at the state of new energy balance achieved after 5 or more months. Similarly, the basal lipolysis, elevated at VLCD, gradually decreases during the subsequent stages of the diet and, at weight maintenance, reaches the levels lower than the pre-diet ones. This pattern of evolution reflects the evolution of energy substrate needs of the body taking into account that AT lipolysis provides the main source of circulating NEFA.
LIPOGENESIS
Insulin stimulation of de novo lipogenesis measured on isolated SCAT adipocytes was blunted after 4-weeks' VLCD. 10 However, in weight-maintenance phase, 1-3 years after initiation of the weight reducing program or after gastric banding, both, the basal-and insulin-stimulated, de novo lipogenesis measured on isolated adipocytes were increased when compared with the pre-diet condition. 31 In agreement with the latter result, Santosa et al. 43 observed a higher postprandial uptake of fatty acids in the upper body SCAT (detected as increased incorporation of H 3 labeled triolein) after weight loss induced by longer dietary program combined with exercise. After 15 weeks' LCD, activity of lipoprotein lipase decreased in femoral as well as in abdominal SCAT in women but not in men. Lipoprotein lipase mRNA expression either did not change (in both depot and both genders) 44 or was decreased after 10 weeks' LCD.
45,46
ATBF ATBF is an essential determinant of the AT metabolism: it affects delivery of hormones and other active substances to the AT, as well as the release of the substance from adipocyte into interstitium and to the circulation. Disturbances of ATBF were shown to be related to insulin resistance. In the dietary intervention studies, assessment of ATBF in situ was performed in abdominal SCAT either using quantitative 133Xe washout method or semi-quantitative ethanol washout method. Several studies on the effect of hypocaloric diets on ATBF are available: no change of ATBF was found following the interventions leading to weight loss o5% of the original body weight (11 days of VLCD 29 or 4 weeks of LCD 27 ), whereas the improvement of ATBF was detected following 4 weeks' VLCD, resulting in weight loss of 9% of original weight. 28, 47 Thus, the magnitude of fat-mass reduction might have a role in the diet-induced effect on ATBF.
ADIPOKINES IN ADIPOSE TISSUE DURING HYPOCALORIC DIET
AT is a powerful endocrine organ and, in fact, many of the proteins secreted either by adipocytes or by the cells of stromavascular fraction (SVF) exert metabolic effects, which may be an underlying cause of obesity-related metabolic disturbances. Consequently it might be hypothesized that the diet-induced improvement of metabolic profile in obese subjects might be associated with the diet-induced modifications of adipokine production in AT.
Recently, we published an extensive and systematic review of the effects of hypocaloric diets on various indices of adipokine production in AT. 48 Therefore, in this overview, this chapter will be limited to the effects of diet on adipokine expression and secretion in AT. In respect to the vast number of studies on the diet-induced changes of plasma levels of adipokines, the reader is asked to refer to the above-mentioned review. mRNA expression of adipokines Leptin. In spite of a large number of studies that show a systematic decrease of leptin plasma levels during hypocaloric diets, the studies exploring the diet-induced evolution of leptin mRNA expression are rare. Both VLCD and 10 weeks' LCD were shown to decrease leptin expression in SCAT. 46, [49] [50] [51] Leptin expression in SCAT remained reduced even 2 years after profound (38 kg) weight loss induced by bariatric surgery. 52 In contrast, short-term (5-6 days) VLCD or fasting did not reduce leptin expression despite the reduction of leptin plasma levels. 53, 54 The results might suggest that not only the calorie restriction per se but also a certain degree of reduction of fat mass is a necessary condition for the diet-induced regulation of leptin. This might be associated with the role of adipocyte size in regulation of leptin expression/secretion: the smaller adipocyte size is associated with lower leptin mRNA expression. 8 Adiponectin. Short-term 55 Adaptation to hypocaloric diet L Rossmeislová et al LCD leading to higher weight loss (15%) or bariatric surgery resulted in an increase of adiponectin expression 57, 58 and in one study, 52 a decrease of mRNA expression was found 2 years after bariatria-induced profound weight loss. In some of the above mentioned studies, 52, 56 a marked dissociation between the dietinduced response of plasma adiponectin (increase) and mRNA expression in SCAT (no change) was observed.
Pro-inflammatory adipokines/chemokines expressed predominantly in cells of SVF. Pro-inflammatory adipokines induce metabolic disturbances in relevant tissues and their expression in AT was shown to be elevated in obesity. Thus, the beneficial metabolic effect of the diet could be associated with the downregulation of their expression. This was proved for IL-6 that decreased after LCD 49 or 6 months after gastric banding 58, 59 and MCP-1 whose expression was found to decrease 3 months after bariatric surgery. 59 As to TNFa, responses of mRNA expression were variable: increase after VLCD, 50 unchanged after LCD 49, 60 or decreased during longer follow-ups: 20 weeks' diet followed by weight-maintenance period 61 or 6 months after profound weight loss induced by gastric banding. 58 Pro-inflammatory adipokines expressed predominantly in adipocytes.
Decrease of mRNA expression of acute phase protein serum amyloid A in SCAT during short-term 62 or long-term 63 VLCD was observed. Expression of retinol-binding protein 4-which was shown to be associated with increased insulin resistancedecreased during VLCD and increased to the pre-diet levels gradually during subsequent weight-maintenance phase (this time course was paralleled by that of retinol-binding protein 4 plasma levels). 64 Other adipokines and nonsecretory genes. Expression of several other adipokines or genes with suggested role in pathogenesis of insulin resistance and pro-inflammatory state during weight-reducing dietary interventions was investigated. Expression of visfatin, a putative insulinosensitizer, increased 60 and that of apelin and apelin receptor were reduced 65 after 3-months' LCD. The Gothenburg group demonstrated that two inhibitors of angiogenesis whose expression is enhanced in obesity, tenomodulin 66 and adipocyte-derived pigment epitheliumderived factor, 51 were downregulated after long-term VLCD followed by a 2 weeks' weight-maintenance period. The data on tenomodulin were confirmed also by Kolehmainen et al. 67 In addition, weight loss induced by the hypocaloric diet reduced levels of CIDEC, a protein associated with lipid droplets and involved in the regulation of lipolysis, 68 and SPARC/ osteonectin, 46 ,69 a protein with profibrotic effects.
Secretion of adipokines
Although the actual secretion of the adipokines from AT is crucial for assessment of the contribution of AT to the circulating levels of the given adipokine, only few studies explored adipokine secretion by SCAT explants obtained before and during the dietary intervention. After 10 weeks' LCD, Arvidsson et al. 49 found a decrease of secretion of leptin, TNFa, IL 6 and IL-8 with no change in secretion of adiponectin and PAI-1. Secretion of adiponectin and its multimeric forms were not changed after 28 days' VLCD. 70 TNFa secretion was also decreased after 20 weeks' intervention in the study of Bruun et al.
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In our recent study 71 exploring secretion and expression of multiple adipokines during multi-phase dietary intervention, identical to that used in the study of Capel et al. 72 (see next paragraph), we found that (1) there is a similar pattern of the dietinduced response in mRNA expression and secretion of the given adipokine, (2) both, expression and secretion, show different response during VLCD as compared with subsequent weight- Adaptation to hypocaloric diet L Rossmeislová et al maintenance phase and (3) the pattern of the response differs in adipocyte-derived as compared with SVF-derived adipokines These results suggest a distinct regulation of adipocyte-and macrophage-related genes. This was confirmed and demonstrated in the studies that investigated the diet-induced changes of the large gene profiles using microarray approach that are presented in the next paragraph of this review. Details of the studies dealing with the effects of hypocaloric diets on adipokine and cytokine expression are presented in Table 2 .
THE DIET-INDUCED EFFECT ON GENE PROFILE-USE OF TRANSCRIPTOMICS
Several studies investigated a large panel of genes regulated in SCAT during hypocaloric diets using transcriptomics (microarray) approach. The first report comes from the study of Clement et al. 73 The authors compared mRNA-expression profile of the inflammation-related genes at the end of 28 days' VLCD with the profile at the pre-diet condition. They found 100 genes to be regulated during the diet: the genes related to acute phase response, differentiation or encoding pro-inflammatory cytokines were mostly downregulated, whereas genes encoding antiinflammatory cytokines or interleukins (for example, IL-10) belonged to upregulated group. Thus, the authors concluded that the short-term VLCD reduced markedly the pro-inflammatory status of AT.
Following results on the diet-induced change in gene profiling resulted from NUGENOB (Nutrient-gene interactions in human obesity, www.nugenob.org) study that consisted of a 10 weeks' LCD with two arms: one with low (20-25% of total energy) and the other with moderate (40-45% of total energy) fat content. In the report of Dahlman et al. 74 evaluating 23 subjects, 2.5% of more than 3500 investigated genes were found to be regulated during the dietary intervention. Out of them, the genes involved in the synthesis of polyunsaturated fatty acids were the most profoundly decreased during energy restriction. Importantly, there was no difference in gene regulation between the two arms of macronutrient diet composition and, thus, it appears that the energy restriction plus weight loss are more important determinants of the diet-induced gene-expression changes than the diet macronutrient composition. This was concluded also in the preceding report based on the NUGENOB study and evaluating expression of 38 selected genes. 46 In a larger (24 000 genes) microarray analysis of NUGENOB subjects, Capel et al. 45 found 1000 genes to be regulated: the downregulated genes were involved again in unsaturated fatty-acid synthesis, as well as synthesis of saturated fatty acids and TAG storage capacity (for example, lipoprotein lipase). In yet another analysis of NUGENOB subjects, Mutch et al. 75 investigated whether the pre-diet profile of gene mRNA expression in SCAT could be a predictor of the individual response (that is, higher weight loss) to the diet. Even though data analysis revealed that the gene-expression profiles of responders could be differentiated from non-responders (100 genes differentially expressed, e.g. prostaglandin D2 synthase, fibromodulin or endothelial cell adhesion molecule) authors concluded that the gene profile may serve only as a weak predictor of the diet-responsive (i.e. weight losing) subjects.
Differentiation power of gene-expression profiling was investigated also in DiOGenes study, 76 with the aim to predict ability of post obese subjects to successfully maintain weight loss induced by hypocaloric diet. In details, the initial 8 weeks' VLCD (resulting in the weight loss corresponding to 8% of original weight) was followed by 6 months' follow-up with ad libitum diet. The participants were then divided into 2 groups characterized by low or high weight regain during weight maintenance phase. Subjects with continued weight loss were characteristic by VLCD-induced upregulation of the genes regulating fatty acid metabolism and apoptosis and downregulation of genes related to extracellular matrix (ECM) remodeling, while those regaining the weight showed opposite expression pattern.
In addition to DiOGenes other studies paid attention to the long-term diet-induced regulation of the gene-expression profile. 33 weeks' study of Kolehmaienen et al. 67 associated with the mild weight loss in elderly subjects observed a downregulation of genes belonging to gene ontology groups of ECM and cell death. Contrary to that, study of Dankel et al. 77 examining morbidly obese subjects one year after profound weight loss induced by bariatric surgery found that the genes expression of ECM structural proteins was enhanced. Nevertheless, majority of genes influenced by massive weight loss was downregulated, e.g. including those involved in cytokine/chemokine-and macrophage-and granulocyte-mediated immunity and stress response.
As the discrepancies in some of the results of the above mentioned studies might be due to the severity and length of calorie restriction, the studies investigating the gene-expression profile during several time points of a long term dietary intervention should provide better insights into the dynamics of gene-expression changes. Capel et al.
72 studied mRNA-expression profile in SCAT at baseline, after 28 days' VLCD and then after 5 months, at the end of the weight-maintenance period. A total of 1535 genes were regulated during at least one phase of the diet, most of them being downregulated. The regulation was markedly different (1) in respect to the phase of the diet and (2) in respect to the functional group of respective genes: the genes related to metabolism and expressed predominantly in adipocytes (mainly genes regulating unsaturated fatty-acid synthesis, the glycolytic pathway or mitochondrial metabolism) were downregulated during VLCD and their expression increased during the subsequent period, whereas the genes related to immune functions and expressed predominantly in SVF cells (mainly macrophage-specific markers including some of the macrophage-secreted products) were not regulated or upregulated during VLCD and downregulated during subsequent phase. In addition, the opposite pattern of regulation of adipocyterelated and macrophage-related genes suggests an interaction between the two cell populations, which is functional during the dietary intervention (see next paragraph for more details). In another study that used the multiphase dietary approach and targeted partly the same topic, that is, differentiation of the gene response to the calorie restriction per se as compared with the weight loss, Franck et al. 51 found a downregulation of genes involved in fat storage during calorie restriction, in a clear agreement with all the studies mentioned here above.
Altogether, acute caloric restriction leading to the weight loss appears to be accompanied with the reduction of expression of metabolism-related genes, for example, enzymes involved in unsaturated fatty-acid synthesis. On the other hand, the proinflammatory and macrophage-related genes tend to be rather upregulated in response to acute negative energetic balance. This pattern is reversed upon the establishment and maintenance of the newly acquired and stable weight. Other gene ontology groups, such as ECM, cell death and proliferation, are also affected by the hypocaloric diets; however, more studies clarifying their response pattern are needed to enable general conclusions.
MACROPHAGE CONTENT IN ADIPOSE TISSUE AND HYPOCALORIC DIET
As mentioned in previous two paragraphs the diet induced changes in the expression of genes related to adipocytes as well as those related to cells of SVF of AT, namely macrophages. The latter changes may be associated with modifications of expression of macrophage-related genes, as well as with modification of macrophage recruitment (content) in AT. In fact, macrophages infiltration in AT is increased in obese humans 78, 79 and is related to pro-inflammatory status of obese individuals. 80 It may be hypo- Several studies using microarray approach and mentioned in previous paragraph suggest a decrease of macrophage-derived genes during the diet. 72, 73 Moreover, decrease of macrophage infiltration in SCAT in morbidly obese subjects examined 3 months after gastric bypass was confirmed by the immunohistochemistry. 59 As the reduction of expression of chemoattractant substance, such as MCP-1, PLAUR, CSF-3, and HIF-1, was reduced as well in the same study, it may be hypothetized that they might have a role in the diet-induced changes of AT macrophage content. In another study, that used flow cytometry analysis for assessment of macrophage content in SCAT, we observed a reduction of macrophage content in SCAT at the end of the 6-months' dietary program. 81 Tissue macrophages are supposed to present different activation states: either proinflammatory, classically activated by interferon-g, or lipopolysaccharide, known as M1, or antiinflammatory, alternatively activated by IL-13 or IL-4, known as M2. Depending on microenvironmental stimuli, M1-and M2-activated macrophages fulfill different functions through the production of pro-or anti-inflammatory factors. 82 However, in humans, the phenotypic diversity of macrophages in AT is now known to include more than two types and, thus, requires an expansion of the simple concept of an M2 to M1 shift with obesity. Several studies investigated a tempting hypothesis, whether the beneficial effects of the diet are mediated not only by reduction of macrophage content but also, in addition, by a shift from more to less pro-inflammatory phenotype of AT macrophages. Using immunohistochemistry, Aron-Wisniewsky et al. found in patients examined 3 months after gastric bypass that M1/M2 ratio (characterized by CD40-positive/CD206-positive cells) decreased during the intervention. 83 In contrast, in the above-mentioned study using flow cytometry, 81 no shift in macrophage phenotype (characterized by CD16-positive or -negative cells within the set of CD45/14/206-positive cells) was observed at the end of 6-months' dietary intervention. The difference between the two studies might suggest that the phenotype shift may be reached in condition of (a) high initial body weight (and, consequently, high initial macrophage infiltration) and (b) high magnitude of weight loss.
The study of Kovacikova et al. 81 attracts, in addition, attention to the time-pattern of the evolution of macrophage infiltration during dietary intervention. In fact, the subjects were submitted to the same multiphase dietary intervention as that described in the study of Capel et al. 72 Although the macrophage content decreased at the weight-maintenance state of intervention, it was unchanged at the end of VLCD that initiated the dietary intervention. Thus, this time-pattern was parallel to that of macrophage-related genes in the study of Capel et al. 72 That study suggested for the first time the existence of interaction between macrophages and adipocytes during the multiphase dietary intervention in humans. The same opposite regulation of the macrophage-derived and adipocyte-derived genes was observed in a cross-sectional study using transcriptomics of SCAT and visceral AT: adipocyte-derived genes are downregulated and the macrophage-related ones upregulated with increasing body mass index and insulin resistance. 84 Importantly, it is also similar to the results obtained in mice 85 that showed similar pattern of dynamic response of macrophage content in perigonadal AT, that is, increase of macrophage content after 3 days of hypocaloric diet and decrease bellow the pre-diet levels at day 21 of the diet. The finding of this pattern generates interesting hypothesis on the factors that control the macrophage infiltration in AT, namely, on the role of adipocytes and their products in this regulation. Kosteli et al. 85 observed that the pattern of macrophage content evolution during the diet is similar to that of the rate of lipolysis in AT explants. They suggested that the lipolysis products released from adipocyte, namely NEFA, could trigger macrophage recruitment into AT. Thus, NEFA would represent one of mediators of the adipocyte-macrophage crosstalk in AT. This was further supported by Kosteli's findings of an increase of macrophage content induced by administration of selective b3-agonist CL316234 or by 24 h fast in mice. 85 In addition to adipocyte-macrophages axis, the results of Kosteli also suggest an inverse direction of the interaction: regulation of lipolysis in adipocytes by a change in macrophage phenotype.
However, besides fatty acids, other adipocyte-derived chemoattractants, such as MCP-1, 86 may have a role in the differential macrophage recruitment during dietary intervention. Adipocytes pretreated and hypertrophied with palmitate presented enhanced expression of MCP-1. 87 In our recent study, MCP-1 expression and secretion showed, during multiphase dietary intervention, the time-pattern similar to that of AT macrophage: a nonsignificant tendency to increase at VLCD and decrease at the weightmaintenance state. 71 
FIBROSIS OF ADIPOSE TISSUE AND HYPOCALORIC DIET
Fibrosis of AT has been described recently as an important morphological adaptation of AT in obesity. 88 AT fibrosis is 89 and, thus, pathogenesis of fibrosis may be considered as an another expression of macrophagepreadipocyte interactions in AT. Subjects with high fibrosis in SCAT reached lower weight loss during weight reduction induced by bariatric surgery, 90 suggesting that this interaction may be extended to adipocytes, namely to their capacity to mobilize intracellular triglycerides.
IMPACT OF THE FAT DEPOT
Subcutaneous abdominal vs gluteal/femoral fat No systematic attention was paid to these fat-depot-related differences in AT adaptation to diet and there are just a few studies on lipolysis regulation that compared the two ATs. During LCD, the increase in b-adrenergic stimulation of lipolysis was more pronounced in the subcutaneous abdominal than in the femoral fat depot and this suggested a preferential fat mobilization from the abdominal depot. 12 The higher lipolytic responsiveness in abdominal SCAT may be associated with the higher reduction of adipocyte size in abdominal SCAT when compared with gluteal SCAT observed in the study of Smith et al. 91 On the other hand, LCD-induced decrease of lipoprotein lipase activity was the same in both depots. 44 Visceral fat vs subcutaneuous fat For obvious reasons no prospective studies of the diet-induced change of AT characteristics have been done in visceral fat. Nevertheless, it is to be noted that visceral fat mass is the one that is preferentially reduced (as compared with the subcutaneous abdominal one) during modest weight loss and during VLCDs with duration up to 4 weeks. 92 During longer dietary interventions and/ or larger weight loss, the contribution of the two fat depots tends to equalize. Thus, it might be hypothesized that the diet-induced beneficial metabolic effects (including the reduction of insulin resistance) during short-term dietary interventions might be triggered preferentially by changes in visceral AT as compared with those in abdominal SCAT. However, in our recent crosssectional study, 84 we found that the expression of relevant genes in abdominal SCAT is as discriminating as the expression in visceral AT in respect to insulin resistance and features of metabolic syndrome. Nevertheless, discussion on the relative impact of visceral versus subcutaneous abdominal fat on pathogenesis of obesity-related metabolic disorders is beyond the frame of this article.
CONCLUSION
In summary, hypocaloric weight-reducing diets modify markedly metabolic, endocrine and morphological characteristics of obese AT towards those of lean AT. The diet-induced changes in AT are probably triggered by the calorie restriction per se as well as by the reduction of fat mass. Accordingly, it appears that the effects of hypocaloric diets on AT characteristics vary in respect to the duration and, possibly, degree of calorie restriction. During the ongoing calorie restriction (dynamic phase), as is the case at the end of VLCD or LCD, the primary regulatory factor is the negative energy balance. In AT, it induces a downregulation of the energy storage processes and metabolism, possibly in parallel with the whole-body decrease of the resting metabolic rate. During this stage, cytokines secreted by adipocytes are downregulated, whereas cytokines produced by SVF cells have tendency to increase. Despite the opposing response of adipocytes and SVF cells, downregulation of the whole-body pro-inflammatory state expressed by the decrease of plasma inflammatory markers (for example, CRP) is observed already in these early stages of the dietary intervention. Once the body reaches a new energy balance, reflected by body-weight maintenance, the weight loss-induced remodeling of AT (that includes a lowering of the pro-inflammatory potential of SVF cells) is the primary event.
The AT changes induced by the diet do not, in most of the cases, correlate with the diet-induced whole-body changes of indices of metabolic syndrome, such as insulin resistance and plasma levels of lipids. Thus, it is probable that the diet-induced changes in other tissues and/or the regulatory pathways, such as secretion of gut hormones, liver function and morphology, brain-mediated regulation of metabolism, composition of gut microflora and so on, do contribute to the diet-induced metabolic modifications. Thus, further research of beneficial metabolic effects of hypocaloric diets should be aimed on integration of the diet-induced adaptations of AT with those occurring in other organs/tissues.
